ArticleCancers2023

Chemotherapeutics Used for High-Risk Neuroblastoma Therapy Improve the Efficacy of Anti-GD2 Antibody Dinutuximab Beta in Preclinical Spheroid Models.

Sascha Troschke-Meurer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.